Blood Pressure, Dietary Modification
Conditions
Brief summary
The present record represents a secondary data analysis of the Dietary Approaches to Stop Hypertension (DASH) trial. Study data and specimens were accessed through the National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Coordinating Center (BioLINCC). A global, untargeted, metabolomic profile was used to investigate biomarkers of the DASH dietary pattern as well as blood pressure change.
Detailed description
The present study was conducted in order to: 1) quantify the metabolomic expression of the DASH dietary pattern; and 2) examine the relationship between metabolites that reflect the DASH dietary pattern and blood pressure change. This secondary data analysis leverages the completed DASH trial, a randomized feeding trial (N=459).
Interventions
BEHAVIORALDASH diet
Diet intervention
BEHAVIORALFruits and vegetables diet
Diet intervention
BEHAVIORALControl diet
Diet intervention
Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Johns Hopkins Bloomberg School of Public Health
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
22 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Men and women with systolic blood pressure \<160 mmHg and diastolic blood pressure 80-95 mmHg
Exclusion criteria
* Taking anti-hypertensive medication * Poorly controlled diabetes mellitus * Hyperlipidemia * Cardiovascular event within the past 6 months * Chronic disease that may interfere with participation * Pregnancy or lactation * Body mass index \> 35 kg/m2 * Unwilling to stop taking vitamin or mineral supplements or antacids * Kidney disease * Consumption of \>14 alcoholic beverages per week * Did not consent to the use of biological specimens * Did not attend the 8 week follow-up visit * No serum specimen or insufficient volume of serum specimens in repository
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum metabolites | 8 week follow-up visit | Metabolites were measured using a global, untargeted, metabolomic platform in serum specimens collected at the end of the 8 week diet intervention in the DASH trial. Reverse phase, untargeted ultrahigh-performance liquid chromatography tandem mass spectrometry quantification was used to measure metabolites. Peaks were quantified by calculating the area under the curve. Data were normalized to account for day-to-day instrumental variation. Compounds were identified by comparison to a library of purified standards or recurrent unknown entities and matches were determined based on retention time, mass-to-charge ratio, and chromatographic data. A relative measure of each metabolite (not absolute) is determined. The Metabolon (Durham, NC) platform quantifies over 1,000 compounds representing a broad range of metabolic compounds, including amino acids, carbohydrates, cofactors and vitamins, energy, lipids, nucleotides, peptides, and xenobiotics (chemicals, drugs, and food components). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blood pressure | 8 week follow-up visit | The change in blood pressure was defined as the blood pressure level at the end of the 8 week diet intervention minus the blood pressure level at baseline. |
Outcome results
None listed